Accepted Manuscript Antibiofilm formation and anti-adhesive property of three mediterranean essential oils against a foodborne pathogen Salmonella strain Hanene Miladi, Donia Mili, Rihab Ben Slama, Sami Zouari, Emna Ammar, Amina Bakhrouf PII:
S0882-4010(15)30018-8
DOI:
10.1016/j.micpath.2016.01.017
Reference:
YMPAT 1762
To appear in:
Microbial Pathogenesis
Received Date: 12 June 2015 Revised Date:
15 January 2016
Accepted Date: 19 January 2016
Please cite this article as: Miladi H, Mili D, Ben Slama R, Zouari S, Ammar E, Bakhrouf A, Antibiofilm formation and anti-adhesive property of three mediterranean essential oils against a foodborne pathogen Salmonella strain, Microbial Pathogenesis (2016), doi: 10.1016/j.micpath.2016.01.017. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
Antibiofilm formation and anti-adhesive property of three
2
mediterranean essential oils against a foodborne pathogen
3
Salmonella strain
4
Hanene Miladi1,2,*, Donia Mili3, Rihab Ben Slama1, Sami Zouari4, Emna Ammar2, Amina
5
Bakhrouf1
6
1
7
Faculty of Pharmacy, Monastir, Tunisia;
8
2
9
Engineering School, Sfax, Tunisia
RI PT
1
SC
Laboratory of Analysis, Treatment and Valorisation of Environment Polluants and Products,
M AN U
UR Study & Management of Urban and Coastal Environments, LARSEN—National
10
3
Laboratory of Biochemistry, Faculty of Medicine, Monastir, Tunisia
11
4
Range Ecology Laboratory, Arid Land Institute of Medenine, Medenine, Tunisia
13
TE D
12
* Corresponding author: Hanene MILADI
15
Laboratory of Analysis, Treatment and Valorisation of Environment Polluants and Products,
16
Faculty of Pharmacy, Monastir
17
E-mail:
[email protected] 18
Phone: +216 97 776 410; Fax: +216 73 461 830
AC C
EP
14
19 20 21 22
4
ACCEPTED MANUSCRIPT
Abstract
24
Plant extracts, and their essential oils (EOs) are rich in a wide variety of secondary
25
metabolites with antimicrobial properties. Our aim was to determine the bioactive compound
26
in three mediterranean essential oils belonging to Lamiaceae family, Satureja montana L.,
27
Thymus vulgaris L. and Rosmarinus officinalis L., and to assess their antimicrobial,
28
antibiofilm and anti-adhesive potentials against a foodborne pathogen Salmonella strain.
29
The antibacterial activity of EOs and its biofilm inhibition potencies were investigated on 2
30
reference strains Salmonella typhimurium and 12 Salmonella spp. isolated from food. Biofilm
31
inhibition were assessed using the 2, 3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-
32
tetrazolium-5-carboxanilide (XTT) reduction assay.
33
The analytical data indicated that various monoterpene hydrocarbons and phenolic
34
monoterpenes constitute the major components of the oils, but their concentrations varied
35
greatly among the oils examined. Our results showed that S. montana L. and T. vulgaris L.
36
essential oils possess remarkable anti biofilm, anti-adhesive and
37
compared to R. officinalis EO. There is an indication that Rosmary EO might inhibit biofilm
38
formation at higher concentrations. Therefore, the witer savory and thyme EOs represent a
39
source of natural compounds that exhibit potentials for use in food systems to prevent the
40
growth of foodborne bacteria and extend the shelf life of the processed food.
41
Keywords: Essential oils; chemical composition; antimicrobial activity; biofilm inhibition;
42
anti-adhesive property; Salmonella spp.
SC
M AN U
TE D
EP
bactericidal properties,
AC C
43
RI PT
23
44 45 46 47
5
ACCEPTED MANUSCRIPT
1. Introduction
49
Bacteria are traditionally thought to grow only in a planktonic structure. However, they can to
50
easily survive in hostile environmental conditions as structure embedded in extracellular
51
matrix called biofilm [1, 2]. Pathogenic bacteria develop a number of mechanisms causing
52
damage disease in their hosts and they express a wide range of molecules that adhere to host
53
cell-surface [3, 4]. Adhesion of pathogenic bacteria to host cell surface is a crucial event in
54
colonisation and infection [5]. A biofilm is a microbial-derived sessile community
55
characterised by cells that attach to an interface, embedded in a matrix. Depending on the
56
species involved, the microcolony may be composed of 10–25% cells and 75–90%
57
extracellular polymeric substances (EPS) matrix [6]. Elhariry et al. (2014), showed that some
58
food-related pathogens such as Bacillus spp. and Pseudomonas spp. are recognised to form a
59
stable biofilms in food-processing environments [3]. The presence of biofilms in food
60
processing environments is a potential source of contamination that may lead to food spoilage
61
[7, 8] and allow them to trap nutrients and withstand hostile environmental conditions [1]. It is
62
believed that 99% of bacteria in nature exist in a biofilm [9, 10]. This structure is a very
63
important step in the pathogenicity and drug resistance resistance to conventional antibiotics
64
as well as to host immune system [11, 12]. Biofilm provides protection for the bacteria against
65
antimicrobials and other living cells so that cells in biofilm are about 1000 times more
66
resistant to antimicrobial agents [13, 14]. It is believed that about 60% of microbial infections
67
are caused by biofilms [15].
68
Salmonella infection constitutes a major public health problem in many countries and millions
69
of cases of salmonellosis are noticed worldwide [16]. It has been reported that biofilm may
70
confer bacterial resistance against several environmental stresses, antibiotics, disinfectants
71
and the host immune system [17].
AC C
EP
TE D
M AN U
SC
RI PT
48
6
ACCEPTED MANUSCRIPT For this reason, Food preservation has become a complex problem. New food products are
73
frequently being introduced onto the market. Generally, they require a longer shelf life and
74
greater assurance of freedom from foodborne pathogenic organisms [18]. There is therefore
75
still a need for new methods of reducing or eliminating foodborne pathogens [19]. In this
76
respect, essential oils and other extracts of plants have evoked interest as sources of natural
77
products [20, 21]. They have been screened for their potential uses as alternative food
78
additives in order to prevent the growth of foodborne pathogens or to delay the onset of food
79
spoilage [22, 23, 24, 25]. The compounds are widely accepted because of the perception that
80
they are safe and have a long history of use in folk medicine for the prevention and treatment
81
of diseases and infections [26, 27].
M AN U
SC
RI PT
72
In this context, essential oils derived from plants of Satureja montana L., Thymus vulgaris
83
L. and Rosmarinus officinalis L. which are a common household plant grown in many parts of
84
the mediterranean region and belongs to the Lamiaceae family [25] have been used in food
85
industry as flavouring agents, antioxidants and antimicrobials as well as in cosmetics industri
86
[18, 28]. They are a rich source of biologically active compounds mainly monoterpenes,
87
sesquiterpenes, and their oxygenated derivatives such as alcohols, aldehydes, esters, ethers,
88
ketones, and phenols which may be involved in its physiological and biological activities [29,
89
30].
90
This study was therefore undertaken to determine the bioactive compounds in some
91
commonly used dietary and medicinal plants and evaluate they antimicrobial and antibiofilm
92
effect against some adherents Salmonella spp. where blocking bacterial adhesion to host
93
surfaces provides potential approach to control the microbial infections.
AC C
EP
TE D
82
94 95 96
7
ACCEPTED MANUSCRIPT
2. Materials and methods
98
2.1. Microorganisms and condition for cultivation
99
Salmonella typhimurium ATCC 1408; Salmonella typhimurium LT2 DT104 and 12
100
Salmonella spp. isolated from food were used in this study which was kindly provided by
101
Prof. Rhim Amel from the Regional Laboratory of Public Health of Monastir (Tunisia).
102
Bacteria were cultured in tryptic soy broth (TSB) (Biorad, France). Inocula were prepared by
103
adjusting the turbidity of the medium to match the 0.5 McFarland Standard Dilutions of this
104
suspension in 0.1 % peptone (w/v) solution in sterile water inoculated on TSB to check the
105
viability of the preparation. The bacterial cultures were maintained in their appropriate agar
106
slants at 4 °C throughout the study and used as stock cultures.
107
2.2. Plant material and essential oil extraction
108
Aerial parts of Satureja montana L., Thymus vulgaris L. and Rosmarinus officinalis L.,
109
belonging to the Lamiaceae family, were freshly collected in 2011 during the period of full
110
flowering on the mountain in the south of France (Mediterranean climate country and
111
mountainous region). A voucher specimens of evert plant were taxonomically identified
112
according to the forester flora of France [31]. Dry aerial materials of plants were subjected to
113
hydrodistillation for 3 h with 500 mL distilled water using a Clevenger-type apparatus
114
according to the European Pharmacopoeia [32]. The EO was collected and dried over
115
anhydrous sodium sulfate and then stored in sealed glass vials in darkness at 4 °C prior to
116
analysis. EOs yield was calculated based on dryweight.
117
2.3. Essential Oil Analyses
118
2.3.1. Gas Chromatography/Mass Spectrometry (GC/MS)
AC C
EP
TE D
M AN U
SC
RI PT
97
119
The volatile compounds isolated by hydrodistillition were analysed using gas
120
chromatography–mass spectrometry (GC–MS). The GC–MS analyses were carried out using
121
an Agilent Technologies 6890N GC. The fused HP-5MS capillary column (the same as that 8
ACCEPTED MANUSCRIPT used in the GC/FID analysis) was coupled to an Agilent Technologies 5973B MS (Hewlett-
123
Packard, Palo Alto, CA, USA). The oven temperature was programmed as previously (50 °C
124
for 1 min, then 7 °C/min to 250 °C, and then left at 250 °C for 5 min). The injection port
125
temperature was 250 °C and that of the detector was 280 °C (split ratio: 1/100). The carrier
126
gas was helium (99.995% purity) with a flow rate of 1.2 ml/min. The MS conditions were as
127
follow: ionization voltage, 70 eV; ion source temperature, 150 °C; electron ionization mass
128
spectra were acquired over the mass range 50 to 550 m/z.
129
2.3.2.Volatile Compounds Identification
130
Components were identified on the basis of gas chromatographic retention indices, mass
131
spectra from Wiley 275 mass spectra libraries (software, D.03.00). The relative amounts of
132
each individual component of the essential oils was expressed as the percentage of the peak
133
area relative to total peak area. Kovats retention indices were calculated for each seperate
134
component against n-alkanes mixture (C8–C26) [33] and to those previously reported in the
135
literature [34, 35].
136
2.4.Antimicrobial Activity
137
2.4.1.Determination of minimal inhibitory concentrations
EP
TE D
M AN U
SC
RI PT
122
The minimal inhibitory concentration (MIC) and minimum bactericidal concentration
139
(MBC) of EOs) on planktonic cells were determined in Mueller–Hinton Broth (MHB) using a
140
microtitre broth dilution method as recommended by the Clinical and Laboratory Standards
141
Institute [36]. The inoculums of the bacterial strains were prepared from 12 h broth cultures,
142
and suspensions were adjusted to 0.5McFarland standard turbidity. EOs were dissolved in
143
10% dimethylsulfoxide (DMSO) and then with MHB as required. Cell suspensions (200 µL)
144
were inoculated into the wells of 96-well microtitre plates to get the final concentration
145
ranging from 0.0488 to 50 mg/mL for S. montana L. and T. vulgaris L. EOs and from 0.1953
146
to 200 mg/mL for R. officinalis L. The wells containing only MHB and MHB with inoculum
AC C
138
9
ACCEPTED MANUSCRIPT were employed as negative and positive controls, respectively. The plates were incubated at
148
37°C for 18 h - 24 h. The lowest concentration of the tested samples, which did not show any
149
visual growth of tested organisms after macroscopic evaluation, was determined as MIC,
150
which was expressed in mg/ml. Each assay was performed in triplicate for all bacteria.
151
2.4.2. Determination of Minimum bactericidal concentration
152
In order to determine the minimum bactericidal concentration (MBC) values, 10 µL of each
153
well medium with no visible growth was removed and inoculated in Mueller–Hinton plates
154
(MH). After 24 h of incubation at 37°C, the number of surviving organisms was determined.
155
MBC was defined as the lowest concentration at which 99% of the bacteria were killed. Each
156
experiment was repeated in triplicate [37].
157
2.5. Biofilm inhibition assays
158
2.5.1. Assessment of biofilm metabolic activity using XTT reduction assay
159
The metabolic activity of cells in biofilm was assessed using the XTT [2, 3-bis (2-methyloxy
160
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] reduction assay according to methods
161
described previously [1, 38] which measures the reduction of a tetrazolium salt by
162
metabolically active cells to a coloured water soluble formazan derivative that can be easily
163
quantified colorimetrically.
164
Each EOs was tested for its potential to prevent biofilm formation of all strains. The EOs were
165
added to the growth medium at the time of inoculation and the cells were allowed to form
166
biofilms [1]. Prevention of biofilm formation by every EO was examined by microdilution,
167
similar to the MIC assay for planktonic cells. A two-fold serial dilution of EOs (final
168
concentrations from 0 to 25 mg/mL for S. montana L.and T. vulgaris L. and from 0 to 200
169
mg/mL for R. officinalis L.) was prepared in 96-well polystyrene tissue culture plates
170
containing TSB broth with 2% glucose (w/v).
AC C
EP
TE D
M AN U
SC
RI PT
147
10
ACCEPTED MANUSCRIPT The medium without EO was used as the non-treated well and the medium with EO as the
172
blank control.
173
XTT (Sigma-Aldrich, Switzerland) solution (1 mg/ml) was prepared in PBS, filter sterilized
174
and stored at -80 °C. Menadione (Sigma-Aldrich, Switzerland) solution (1 mM) was prepared
175
in acetone and sterilized immediately before each assay.
176
Aliquots of bacterial suspension (10 µL) were inoculated in tissue culture plate wells (5.104
177
cfu/mL, final concentration). Following incubation at 37 °C for 24h, culture supernatants
178
from each well were decanted and planktonic cells were removed by washing three times with
179
phosphate-buffered saline (7 mM Na2HPO4, 3 mM NaH2PO4 and 130 mM NaCl at pH 7.4).
180
Then 100 µl PBS and 12 µl XTT-menadione solution (12.5:1 v/v) were added to each of the
181
prewashed wells and the control wells. The plate was then incubated for 3 h in the dark at
182
37°C. Following incubation, 100 µl of the solution was transferred to fresh wells, and the
183
colour change in the solution was measured with a multiskan reader at 492 nm. The
184
absorbance values for the controls were then subtracted from the values of the tested wells to
185
eliminate spurious results due to background interference. The percentage of biofilm
186
inhibition was calculated using the equation [(OD growth control - OD sample)/ OD growth
187
control] × 100. Each assay was repeated three times.
188
The minimum biofilm inhibition concentration (MBIC50) was defined as the lowest
189
concentration of each EO tested that showed 50% inhibition on the biofilm formation.
190
2.5.2. Microscopic techniques
AC C
EP
TE D
M AN U
SC
RI PT
171
191
Prevention of biofilm formation by each EO was confirmed by microscopic technique of
192
Salmonella typhimurium ATCC 1408 and food isolated Salmonella spp. strain (S1: 6554).
193
Briefly, strains were allowed to grow on round covers glass slides (diameter 1 cm) placed in
194
24-well polystyrene plates (Greiner Bio-One, France) supplemented with every EO extracted
195
from S. montana L., T. vulgaris L. and R. officinalis L. (0, MIC/2, MIC, 2 × MIC), incubated
11
ACCEPTED MANUSCRIPT for 24 h at 37°C and stained with 1/20 Giemsa (Sigma, Switzerland) solution (v/v) for 20 min
197
at room temperature. Stained glass pieces were placed on slides with the biofilm pointing up
198
and were inspected by light microscopy at magnifications ×40 [39].
199
2.5.3. Anti-adhesive property
200
Adhesion test was carried out using A549 (human lung adenocarcinoma epithelial cell line).
201
For the assay, a mixture of 100 µl of 107 cells/ml and A549 cell was treated with every EO
202
extracted from S. montana L. by DL50 and 4 × DL50 concentration (0.4 and 1.6 mg/mL),
203
from T. vulgaris L. by DL50 and 4 × DL50 concentration (0.3 and 1.2 mg/mL) for their 48 h
204
cytotoxic activity and from R. officinalis L. EO by DL50, 4 × DL50 and 8 × DL50
205
concentrations (0.08, 0.32 and 0.64 mg/mL) for their 48 h cytotoxic activity previously
206
decribed [40, 41]. The 24- well plates were incubated at 37°C for 24 h in 5% CO2. After
207
being inspected by optical inversion microscope at magnifications ×40.
208
2.6. Statistical analysis
209
Statistical analysis was performed on SPSS v.17.0 statistics software. Statistical differences
210
and significance were assessed by one-way ANOVA test and Wilcoxon signed ranks test, as
211
appropriate, to evaluate the antimicrobial activity and the biofilm inhibition according the
212
type of strains and the EOs supplementation. A P value < 0.05 was considered significant.
213
3. Results and discussion
214
3.1. Chemical Composition of Essential Oil
215
To determine the chemical composition of the essential oils of S. montana L., T. vulgaris L.
216
and R. officinalis L., conventional GC-MS analyses were performed. The identified
217
components, their percentages, their calculated RI are listed in Table 1, according to their
218
elution order on a HP-5MS column. These analyses revealed that the most important feature
219
of the oils was the presence of a high percentage of oxygenated monoterpenes which varies
220
from 50 to 60% approximately, followed by the monoterpene hydrocarbons by 33.2, 39.85
AC C
EP
TE D
M AN U
SC
RI PT
196
12
ACCEPTED MANUSCRIPT and 42.03 % for S. montana L., T. vulgaris L. and R. officinalis L. EOs respectively. Other
222
classes that are sesquiterpene hydrocarbons and oxygenated sesquiterpenes were also present
223
in small quantities in different oils.
224
In the EO extracted from S. montana L., a single compound, carvacrol, accounted for 53.35 %
225
of the EO, although 32 compounds were identified. ??-terpinene and p-cymene were also
226
found in the EO of S. montana L. as major components (Table 1). Thus, this EO also showed
227
a high content of oxygenated monoterpenes (59.11%) whereas no sesquiterpene compounds
228
were found at quantifiable levels.
229
Satureja montana L. oil showed a large variations in the relative concentration of major
230
components: carvacrol, linalool, γ- terpinene, p-cymene and β-caryophyllene, depending on
231
their geographic origin [42]. Moreover, the essential oil extracted from S. montana grown in
232
Croatia contained Linalool, p-cymene, and γ -terpinene as the main components [43].
233
In contrast, previous work on the phytochemical content of the essential oil of S. montana L.
234
[43] (sample obtained from different country, same maturation stage) has identified linalool as
235
the major component (61.5%). Furthermore, they reported that only a small amount of
236
monoterpene phenols (carvacrol, 0.1%) is present, presumably because their samples have
237
been derived from different chemotypes, and environmental conditions seem to have a
238
significant influence on the relative amounts of EO components of S. montana [44].
239
Moreover, 31 compounds were identified in the EO of T. vulgaris L. This EO consisted
240
mostly of monoterpenes with both nonoxygenated (39.85%) and oxygenated structures
241
(50.88%) and lower contents of sesquiterpene hydrocarbons (5.9%) and oxygenated
242
sesquiterpenes (0.70%). The elevated Thymol content (41.33%) of this EO was highly
243
significant. This constituent, conjointly to p-cymene (18.08%), and γ-terpinene (13.12%), p-
244
Cymene-3-ol (5.24%) and and β-caryophyllene (5.05%) were the major components,
245
representing 82.82% of the oil. Thyme oil was also characterised by the presence of a number
AC C
EP
TE D
M AN U
SC
RI PT
221
13
ACCEPTED MANUSCRIPT 246
of other constituents at concentrations ranging from 0.1% to 2.5% (Table 1). These results are
247
in accordance with previous observations concerning several other thyme populations of the
248
same taxon [19]. Regarding R. officinalis EO, 37 compounds, corresponding to 99.38% of the chemical
250
components in the EO, were identified. Among these, 42.03% were monoterpene
251
hydrocarbons and 52.04% were oxygenated monoterpenes, and it also contained 1.94%
252
sesquiterpene hydrocarbons and 0.79% oxygenated sesquiterpenes. The major constituents of
253
R. officinalis L. EO were 1,8-cineole (24.1%), camphor (19.87%), α-pinene (19.49%),
254
camphene (8.65%), and p-cymene (3.79%), representing 75.9% of the EO. Chemical
255
composition of rosemary oil have already been described. A study carried out by Wang et al.,
256
(2008) [45] confirmed that 1,8-cineole (27.23%), α-pinene (19.43%), camphor (14.26%),
257
camphene (11.52%), and β-pinene (6.71%) were the main constituents of rosemary oil in
258
concentrations. Comparably, the rosemary oil examined in the present study contained large
259
quantities of 1,8-cineole, camphor, and α-pinene, followed by β-pinene (4.84%) and
260
camphene (3.82%). These results are all in agreement with Pintore et al., (2002) [46] who
261
reported that rosemary oil with more than 40% 1,8-cineole was characteristic of plants found
262
in Morocco, Tunisia, Turkey, Greece, Yugoslavia, Italy and France.
263
The observed diversity in chemical composition of the various oils, when compared with
264
those reported in previous studies, could be due to a number of factors. Such factors may
265
include differences in climatic conditions, geographical location, season at the time of
266
collection, stage of development, processing of plant materials before extraction of the oils,
267
and occurrence of chemotypes.
268
3.2. Variation of the antimicrobial activity
269
The bacteriostatic and bactericidal effectiveness of the different EOs estimated by minimum
270
inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) respectively
AC C
EP
TE D
M AN U
SC
RI PT
249
14
ACCEPTED MANUSCRIPT are shown in Table 2 against 2 reference strains of S. typhimurium and 12 food isolated strains
272
belonging to Salmonella genus. The Results indicate a high variation of MICs and MBCs
273
among the three mediterranean EOs and Salmonella spp. strains. Different essential oils
274
showed a significant anti-bacterial activity against all tested strains that confirms previous
275
findings [47, 48]. Differences in chemical composition may also explain the variation
276
observed in antimicrobial activity of the three EOs evaluated, with the winter savory (S.
277
montana L.) EO exhibited the highest anti-microbial activity than that of thyme EO and
278
thereafter followed by the anti-microbial activity of rosemary essential oil.
279
For S. montana L., MIC values were ranging from 0.39 to 0.78 mg/mL. The MBC values
280
were also important, and low concentration of S. montana L. EO was sufficient to eliminate
281
the growth of reference strains S. typhimurium (MBC: 0.78 mg/mL). It has shown also that
282
0.39 mg/mL of this EO was sufficient to stop the growth of several pathogenic food isolated
283
strains of Salmonella species (Table 2).
284
T. vulgaris L. EO demonstrated a significant antimicrobial property. As presented in table 2, it
285
exhibited bactericidal activity on all tested strains with MIC and MBC values ranging from
286
0.78 to 1.56 mg/mL and 1.56 to 3.12. mg/mL, respectively. The major activity of essential
287
oils of S. montana L. and T. vulgaris L. is due to their richness in phenolic compounds
288
(carvacrol and thymol). Most antimicrobial compounds are phenols (carvacrol, thymol,
289
eugenol), followed by alcohol (cineole, linalool ...) and to a lesser extent alkenes (p-cymene,
290
pinene, terpinene ...) [19, 49]. Indeed, several studies have shown that high antimicrobial
291
power of essential oils of several species of Satureja and thyme is attributed to their high
292
phenolic compounds (carvacrol and thymol) [18, 50, 51, 52, 53]. One of the main
293
characteristics of EOs is their hydrophobicity, which enables their incorporation in to the cell
294
membrane [54]. Previous studies reported that EOs contained phenolic compounds with
295
antimicrobial activity against a large number of bacterial strains and exhibits this role through
AC C
EP
TE D
M AN U
SC
RI PT
271
15
ACCEPTED MANUSCRIPT the disruption of the cytoplasmic membrane [55]. The membrane loses its structure and
297
becomes more permeable to ions [56].
298
The antimicrobial activity of rosemary essential oil against a foodborne pathogen Salmonella
299
spp. Strains was less than against the other EOs (Table 2). Oils from R. officinalis L. showed a
300
low bactericidal effect (MICs = 12.5 to 25 mg/mL). However, MBC values of rosemary oil,
301
were even higher than the corresponding MIC values (MBC = 25 to 50 mg/mL). We noted
302
also that the MBC values of rosemary oil were 2-4 times higher than the MICs values.
303
However, R. officinalis EO analysed in this study, even with a high content of 1,8-cineole,
304
showed less antibacterial activity. Actually, this EOs has been previously reported to possess
305
moderate antibacterial activity [57, 58].
306
The Turkish R. officinalis oil possesses a moderate antibacterial activity attributed to the high
307
content of 1.8-cineole, the low content of camphor and verbenone, respectively [59]. A weak
308
activity was reported for samples from Sardinia dominated by α -pinene, camphene,
309
verbenone, bornyl-acetate, camphor and borneol tested against several pathogenic bacteria
310
[57, 58]. Our work showed that the variation of antibacterial activity in french R. officinalis
311
differed according to the quantitative variation of essential oil compounds attributed to both
312
varietal and populational effects corroborating previous works [60, 61]. Considering the high
313
number of the identified compounds in the analysed oils, it would be difficult to attribute the
314
antibacterial activity differences to specific compounds [62].
315
3.3. Inhibition of biofilm formation
316
3.3.1. Effect of EOs on biofilm metabolic activity using XTT reduction assay
317
In the presence of EOs, the metabolic activity of cells in biofilms was distinctly reduced after
318
24 h of incubation (Table 2). Our data also provides preliminary evidence that EO affect the
319
oxidative activity of all the tested strains compared to the non treated biofilm (Table 3). EOs
320
showed a significant inhibitory effect (P < 0.05) on biofilm formation of reference and food
AC C
EP
TE D
M AN U
SC
RI PT
296
16
ACCEPTED MANUSCRIPT isolated strains with a dose dependent manner, while an increase in activity was observed with
322
S. montana L. and T. vulgaris L. EOs. The results indicate that in addition to reducing
323
biomass, most of the EO had an effect on the metabolic activity (Table 3).
324
For S. montana L. EO, the BIC50 was observed with concentration about 0.113 and 0.22
325
mg/mL for S. typhimurium ATCC 1408 and S. typhimurium LT2 DT104 respectively (Table
326
3). For the food isolated strains Salmonella spp., the BIC50 of S. montana L. EO ranges from
327
0.12 to 0.499 mg/mL. We noted also that the two reference strains were more susceptible to
328
the winter savory EO than the others strains. Moreover, his BIC90 varies between from 0.6 to
329
6.45 mg/mL suggesting the ability of S. montana L. EO to prevention of biofilm formation.
330
Prevention of biofilm formation by T. vulgaris L. EO was also confirmed using XTT assay.
331
Thyme oil supplementation between 0.106 and 0.725 mg/mL, can inhibited 50% of biofilm
332
formation of all tested strains market by BIC50 values (Table 3). In addition we showed that
333
BIC90 was obtained after 2.78 and 3.5 mg/mL of T. vulgaris L. EO supplementation for the
334
two reference strains and was more in food isolated strains by 3.12 and 7.25 mg/mL (Table 3).
335
For R. officinalis L. EO, our study showed that rosomary oil might has an inhibitory effect on
336
the biofilm formation at higher concentrations than another EOs which were used in this study
337
(Table 3).
338
A statistical significant difference in prevention of biofilm formation between the treated
339
strains with each EO and control was found (P < 0.001). These results indicated that the
340
different EOs used in this study have an effect on the metabolic activity of cells embedded in
341
biofilm. Inhibition of growth in a preformed biofilm was also successful; however, the extent
342
of inhibition was much less compared to initial attachment. The reduced antibiofilm activity
343
towards a preformed biofilm is evidence that cells in a biofilm are more resistant to
344
antimicrobial agents compared to free-floating cells. Morover, most antibiotics are up to
345
1000-times less efficient against bacteria in biofilm than in suspension [63], which makes EO
AC C
EP
TE D
M AN U
SC
RI PT
321
17
ACCEPTED MANUSCRIPT a very promising treatment alternative. Several author reported that the slower growth rate in
347
biofilms compared to planktonic cells as a result of reduced nutrient and oxygen supply has
348
been reported as an important factor attributed to the resistance in biofilms [14, 64]. Many
349
antimicrobial agents have been shown to be effective against microorganisms that are rapidly
350
growing and dividing, with only a few exceptions known. As a consequence, the slow growth
351
rate observed in biofilms makes them less susceptible to antimicrobial agents that are
352
normally effective against metabolically active cells [15].
353
The increased sensitivity observed in the reference isolate compared to the food isolate
354
confirms previous reports where, food isolates strain were able to withstand harsh
355
environmental conditions compared to type strains [65]. The resistance of clinical isolates in
356
both Gram-positive and Gram-negative bacteria to antibiotics is well known [66]. This has
357
been attributed to prior exposure to antimicrobial agents during therapy or other disinfection
358
processes resulting in secondary ⁄ acquired resistance [67].
359
3.3.2. Prevention of biofilm formation on glass microscope slide covers
360
The effect of three essential oils on biofilm formation of S. typhimurium ATCC 1408 was
361
confirmed by microscopic visualization. As shown in figure 1, a moderate reduction of
362
biofilm formation was observed with each EO supplementation (1/2 MIC) on the strong
363
biofilm formers (S. typhimurium ATCC 1408) whereas the biofilm former was relatively
364
inhibited with MIC from each EO and significantly inhibited with 2 × MIC EO
365
supplementation.
366
For a food isolated strain Salmonella spp. strain (S1), the microscopic visualization (Figure 2)
367
showed that 2 × MIC of the winter savory and Thyme EOs decreased the biofilm formation
368
on glass slides covers but not wholly suppressed. Moreover, we noted that adhesion of food
369
isolated strain on glass slides was completely inhibited by MIC R. officinalis L. EO
AC C
EP
TE D
M AN U
SC
RI PT
346
18
ACCEPTED MANUSCRIPT supplementation. As described above, we showed that the food isolated strain was more
371
resistant that the reference strain.
372
Our results revealed that each of the three EOs efficiently kills Salmonella in suspension and
373
prevent biofilms formation. This effect on biofilm formation was confirmed by microscopic
374
analysis of strains grown on the surface of glass slides covers. Statistical analysis revealed a
375
significant difference between the percentage of biofilm inhibition obtained after EO
376
supplementation (2 × MIC) between treated cells and non treated ones (P < 0.001).
377
3.3.3. Anti-adhesive effect (on A545) of EOs
378
Adhesion of S. typhimurium ATCC 1408 and a food isolated strain Salmonella spp. strain
379
(S1) cells has been studied using cell lines of human origin in culture as in vitro models for
380
human respiratory epithelium. In the present study, adhesion of reference and food isolated
381
strains to A549 cells in absence and presence of 48 h of cytotoxic dose, which has been
382
recorded against A549, was investigated. In the absence of EO, S. typhimurium ATCC 1408
383
and S1 showed an important adhesive ability to A549 cells as presented in figure 3 and 4
384
respectively. They described the anti-adhesive activity of different EOs and shown that
385
DL50×4 EO of each one can attenuate the adhesive ability of S. typhimurium ATCC 1408 and
386
S1 to A549. We also noted that S montana L. EO was more effective for inhibiting bacterial
387
cell adherencethan thyme and rosemary EO, where is used at a concetration of DL50×4. On
388
the other hand, figure 4 showed that the food isolated strain (S1) was less susceptible to EOs
389
which can adhere to A549 celles after exposure to DL50×8 R. officinalis L. EO. So, S1 may
390
acquire some characteristics as a result of their presence in biofilm layers in the environment,
391
where the exposure to environmental stresses leads to alteration of their surface properties
392
[68]. This may explain the obtained results which showed clearly that the biofilm-forming
393
strains of S1 displayed high resistance to the anti-adhesive effect of studied EOs compared
394
with the reference strains (Figure 4).
AC C
EP
TE D
M AN U
SC
RI PT
370
19
ACCEPTED MANUSCRIPT Significant antimicrobial, antibiofilm and anti-adhesive activities of EOs were demonstrated
396
against Salmonella spp. Practically, as anti-adhesion therapy may become feasible for
397
attenuating infectious disease. The winter savory, thyme and rosemary EO can be developed
398
as an effective inhibitor to prevent bacterial cell adhesion to biotic or abiotic surfaces and
399
subsequently inhibiting biofilm formation. This may provide natural protection from the
400
infection by some pathogenic bacteria [69].
401
4. Conclusion
402
Our study showed a potential antibacterial and antibiofilm activity for three mediterranean
403
EOs used as they are able to inhibit the initial stage of biofilm formation and subsequent
404
growth. Although most EOs were able to inhibit cell attachment. Isolation and identification
405
of the constituents that exhibit antibiofilm properties might be essential to include these as
406
alternatives in the control of biofilms. In view of their broad activity, these EOs may find
407
industrial applications as natural preservatives and conservation agents in food industries and
408
as active ingredients in medical preparations.
411 412 413 414 415
SC
M AN U
TE D
EP
410
AC C
409
RI PT
395
416 417 418 419
20
ACCEPTED MANUSCRIPT 420
5. ACKNOWLEDGEMENTS
421
We are grateful to Prof. Rhim Amel from the Regional Laboratory of Public Health of
422
Monastir (Tunisia) for her help to collect the microorganisms.
423
RI PT
424 425
SC
426 427
M AN U
428 429 430
434 435 436 437 438
EP
433
AC C
432
TE D
431
439 440 441
21
ACCEPTED MANUSCRIPT
6. References
443
[1] Sandasi M, Leonard CM, Viljoen AM. The in vitro antibiofilm activity of selected
444
culinary herbs and medicinal plants against Listeria monocytogenes. Lett Appl Microbiol
445
2010; 50: 30–35.
446
[2] Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm
447
Device: new technology for rapid determination of antibiotic susceptibilities of bacterial
448
biofilms. J Clin Microbiol 1999; 37(6):1771-6.
449
[3] Elhariry H, Abuzaid AA, Khiralla GM, Gherbawy Y. Antibiofilm formation and anti-
450
adhesive (to HEp-2 cells) effects of rosemary water extract against some food-related
451
pathogens. Int J Food Sci Tech 2014; 49: 1132–1141.
452
[4] Wilson J, Schurr M, Leblanc C, Ramamurthy R, Buchanan K, Nickerson C. Mechanisms
453
of bacterial pathogenicity. Postgraduate Med J 2002; 78: 216–224.
454
[5] Sharon N. Carbohydrates as future anti-adhesion drugs for infection diseases. Biochimica
455
et Biophysica Acta 2006; 1760: 527–537.
456
[6] Garrett TR, Bhakoo M, Zhang Z. Bacterial adhesion and biofilms on surfaces. Progress in
457
Natural Sci 2008; 18: 1049–1056.
458
[7] Nikolić M, Vasić S, Đurđević J, Stefanović O, Čomić L. Antibacterial and anti-biofilm
459
activity of ginger (Zingiber officinale (Roscoe)) ethanolic extract. Kragujevac J Sci 2014; 36:
460
129–136.
461
[8] Frank JF. Microbial attachment to food and food contact surfaces. Adv. Food Nutr Res
462
2001; 43: 319–370.
463
[9] Al-Shuneigat J, Al-Sarayreh S, Al-Saraireh Y, Al-Qudah M, Al-Tarawneh I. Effects of
464
wild Thymus vulgaris essential oil on clinical isolates biofilm-forming bacteria. IOSR-J D M
465
S 2014; 13: 62–66.
AC C
EP
TE D
M AN U
SC
RI PT
442
22
ACCEPTED MANUSCRIPT [10] Van Houdt R, Michiels CW. Biofilm formation and the food industry, a focus on the
467
bacterial outer surface. J Appl Microbiol 2010; 109: 1117–1131.
468
[11] Kim BS, Park SJ, Kim MK, Kim YH, Lee SB, Lee KH, Choi NY, Lee YR, Lee YE, You
469
YO. Inhibitory Effects of Chrysanthemum boreale Essential Oil on Biofilm Formation and
470
Virulence Factor Expression of Streptococcus mutans. Evid Based Complement Alternat
471
Med 2015; doi: 10.1155/2015/616309.
472
[12] Reid G, Howard J. Gan BS. Can bacteria interference prevent infection. Trends in
473
Microbiol 2001; 9(9): 424–428.
474
[13] Fuente-Nunez C, Mertens J, Smit J, Hancock REW. The bacterial surface layer provides
475
protection against antimicrobial peptides. Appl and Environ Microb 2012; 78(15): 5452–
476
5456.
477
[14] Mah TC, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends
478
Microbiol 2001; 9: 34–39.
479
[15] Lewis K. Riddle of Biofilm Resistance. Antimicrob Agents Ch 2001; 45(4): 999–1007.
480
[16] Sayuri Uchida NS, Grespan R, Piovezan M, Ferreira EC, Machinski Júnior M, Cuman
481
RKN, Mikcha JMG. Effect of Carvacrol on Salmonella Saintpaul Biofilms on Stainless Steel
482
Surface. Trop J of Pharma Research 2014; 13(12): 2021–2025.
483
[17] Steenackers H, Hermans K, Vanderleyden J, De Keersmaecker SCJ. Salmonella
484
biofilms: an overview on occurrence, structure, regulation and eradication. J Food Research
485
Int 2012; 45: 502–531.
486
[18] Chorianopoulos N, Kalpoutzakis E, Aligiannis N, Mitaku S, Nychas GJ, Haroutounian
487
SA. Essential Oils of Satureja, Origanum, and Thymus Species: Chemical Composition and
488
Antibacterial Activities Against Foodborne Pathogens. J Agric Food Chem 2004; 52: 8261–
489
8267.
AC C
EP
TE D
M AN U
SC
RI PT
466
23
ACCEPTED MANUSCRIPT [19] Burt S. Essential oils: their antibacterial properties and potential applications in foods—a
491
review. Int J Food Microb 2004; 94: 223–253.
492
[20] Paiva PMG, Gomes FS, Napolĕao TH, Sa RA, Correia MTS, Coelho LCBB.
493
Antimicrobial activity of secondary metabolites and lectins from plants. In: Current Research,
494
Technology and Education Topics in Applied Microbiology and Microbial Biotechnology
495
(edited by Mendez-Vilas A., 396–406. Badajoz, Spain: FORMATEX, Microbiology Series
496
No 2; 2010.
497
[21] Klančnik A, Guzej B, Kolar MH, Abramovic H, Mozina SS. In vitro antimicrobial and
498
antioxidant activity of commercial rosemary extract formulations. J Food Protect 2009; 72:
499
1744–1752.
500
[22] Alizadeh A. Essential oil composition, phenolic content, antioxidant, and antimicrobial
501
activity of cultivated Satureja rechingeri Jamzad at different phenological stages. Z
502
Naturforsch C 2015; DOI: 10.1515/znc-2014-4121.
503
[23] Friedman M, Henika PR, Mandrell RE. Bactericidal activities of plant essential oils and
504
some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria
505
monocytogenes, and Salmonella enterica. J Food Prot 2002; 65: 1545-1560.
506
[24] Soliman KM, Badeaa RI. Effect of oil extracted from some medicinal plants on different
507
mycotoxigenic fungi. Food Chem Toxicol 2002; 40: 1669-1675.
508
[25] Al-Sereiti MR, Abu-Amer KM,
509
officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol; 1999: 37, 124–130.
510
[26] Kremer D, Bolarić S, Ballian D, Bogunić F, Stešević D, Karlović K, Kosalec I, Vokurka
511
A, Vuković Rodríguez J, Randić M, Bezić N, Dunkić V. Morphological, genetic and
512
phytochemical variation of the endemic Teucrium arduini L. (Lamiaceae). Phytochemistry
513
2015; doi: 10.1016/j.phytochem.2015.04.003.
AC C
EP
TE D
M AN U
SC
RI PT
490
Sen P. Pharmacology of rosemary (Rosmarinus
24
ACCEPTED MANUSCRIPT [27] Guarrera PM. Traditional phytotherapy in Central Italy (Marche, Abruzzo, and Latium).
515
Fitoterapia 2005; 76: 1–25.
516
[28] Chizzola R, Michitsch H, Franz C. Antioxidative properties of Thymus vulgaris leaves:
517
Comparison of different extracts and essential oil chemotypes. J Agric Food Chem 2008; 56:
518
6897-6904.
519
[29] Jeong-Ho L, Byung-Kyu L, Jong-Hee K, Sang Hee L, Soon-Kwang H. Comparison of
520
chemical compositions and antimicrobial activities of essential oils from three conifer trees;
521
Pinus densiflora, Cryptomeria japonica, and Chamaecyparis obtuse. J Microbiol Biotechnol
522
2009; 19: 391-396.
523
[30] Zhang C, Li H, Yun T, Fu Y, Liu C, Gong B, Neng B. Chemical composition,
524
antimicrobial and antioxidant activities of the essential oil of Tibetan herbal medicine
525
Dracocephalum heterophyllum Benth. Nat Prod Res 2008; 22: 1-11.
526
[31] Rameau JC, Mansion D, Dumé G, Gauberville C, Bardat J, Bruno E, Keller R. Flore
527
Forestière Française: Guide Ecologique Illustré, vol. 3, Région Méditerranéenne; 2008.
528
[32] European Pharmacopoeia, Maisonneuve SA, Sainte-Ruffine, France; 1975.
529
[33] Kovàts E. Characterization of organic compounds aliphatic halides, alcohols, aldehydes
530
and ketones. Helvetica Chimica Acta; 1958: 41, 1915-1932.
531
[34] Zouari S, Zouari N, Fakhfakh N, Bougatef A, Ayadi MA, Neffati M. Chemical
532
composition and biological activities of a new essential oil chemotype of Tunisian Artemisia
533
herba alba Asso. J Med Plants Res 2010; 4: 871-880.
534
[35] Adams RP. Identification of essential oil components by gas chromatography/quadrupole
535
mass spectrometry. Allured Publishing Corporation, Carol Stream; 2001.
536
[36] CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow
537
aerobically; approved standard, 7th ed. (M7– A7). Wayne, PA: Clinical and Laboratory
538
Standards Institute; 2006.
AC C
EP
TE D
M AN U
SC
RI PT
514
25
ACCEPTED MANUSCRIPT [37] Magina MD, Dalmarco EM, Wisniewski AJ, Simionatto EL, Dalmarco JB, Pizzolatti
540
MG, Brighente IM. Chemical composition and antibacterial activity of essential oils of
541
Eugenia species. J Nat Med; 2009: 63, 345-350.
542
[38] Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML.
543
Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing.
544
Antimicrob. Agents Chemother; 2005: 49, 2612-2617.
545
[39] Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A. Antibacterial activity of
546
Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial
547
biofilm formation. BMC Complement. Altern. Med 2011; 11: 29-34.
548
[40] Miladi H, Ben Slama R, Mili D, Zouari S, Bakhrouf A, Ammar E. Chemical composition
549
and cytotoxic and antioxidant activities of Satureja montana L. essential oil and its
550
antibacterial
551
http://dx.doi.org/10.1155/2013/275698.
552
[41] Miladi H, Ben Slama R, Mili D, Zouari S, Bakhrouf A, Ammar E. Essential oil of
553
Thymus vulgaris L. and Rosmarinus officinalis L.: gas chromatography-mass spectrometry
554
analysis, cytotoxicity and antioxidant properties and antibacterial activities against foodborne
555
pathogens. Natural Sci 2013b; 5 (6): 729-739.
556
[42] Kûstrak D, Kuftinec J, Blazevic N, Maffei M. Comparison of the essential oil
557
composition of two subspecies of Satureja montana. J Essent Oil Res 1996; 8: (1), 7–13.
558
[43] Milôs M, Radonic A, Bezic N, Dunkic V. Localities and seasonal variations in the
559
chemical composition of essential oils of Satureja montana L. and S. cuneifolia ten. Flavour
560
Fragr J 2001; 16 (3): 157–160.
561
[44] Cazin C, Jonard R, Alain P, Pellecuer J. L’evolution de la composition des essentieles
562
chez divers chemotypes des Sarriette des montangnes (Satureja montana L.) obtenus par
against
Salmonella
spp.
strains.
J
Chem
2013a;
AC C
EP
TE D
potential
M AN U
SC
RI PT
539
26
ACCEPTED MANUSCRIPT l’isolement in vitro des apex. Comptes Rendus de l’Académie des Sciences Paris 1985; (6):
564
237–240.
565
[45] Wang W, Wu N, Zu YG, Fu YJ. Antioxidative activity of Rosmarinus officinalis L.
566
essential oil compared to its main components. Food Chem 2008; 108: 1019–1022.
567
[46] Pintore G, Usai M, Bradesi P, Juliano C, Boatto G, Tomi F. Chemical composition and
568
antimicrobial activity of Rosmarinus officinalis L. oils from sardinia and corsica. Flavour
569
Fragr J 2002; 17: 15–19.
570
[47] Nowak A, Kalemba D, Krala L, Piotrowska M, Czyzowska A. The effects of thyme
571
(Thymus vulgaris) and rosemary (Rosmarinus officinalis) essential oils on Brochothrix
572
thermosphacta and on the shelf life of beef packaged in high-oxygen modified atmosphere.
573
Food Microbiol 2012; 32: 212-216.
574
[48] Smith-Palmer A, Stewart J, Fyfe L. Antimicrobial properties of plant essential oils and
575
essences against five important food-borne pathogens,” Lett Appl Microbiol 1998; 26 (2):
576
118–122.
577
[49] Ultee A, Bennink MH, Moezelaar R. The phenolic hydroxyl group of carvacrol is
578
essential for action against the foodborne pathogens Bacillus cereus. Appl Environ Microbiol
579
2002; 68: 1561–1568.
580
[50] de Oliveira TL, Soares RA, Ramos EM, Cardoso MG, Alves E, Piccoli RH.
581
Antimicrobial activity of Satureja montana L. essential oil against Clostridium perfringens
582
type A inoculated in mortadella-type sausages formulated with different levels of sodium
583
nitrite. Int J Food Microbiol 2011; 144 (3): 546–555.
584
[51] Cristani M, D'Arrigo M, Mandalari G. Interaction of four monoterpenes contained in
585
essential oils with model membranes: implications for their antibacterial activity. J Agric
586
Food Chem 2007; 55 (15): 6300–6308.
AC C
EP
TE D
M AN U
SC
RI PT
563
27
ACCEPTED MANUSCRIPT [52] Di Pasqua R, Betts G, Hoskins N, Edwards M, Ercolini D, Mauriello G. Membrane
588
toxicity of antimicrobial compounds from essential oils. J Agric Food Chem 2007; 55 (12):
589
4863–4870.
590
[53] Di Pasqua R, De Feo V, Villani F, Mauriello G. In vitro antimicrobial activity of
591
essential oils from Mediterranean Apiaceae, Verbenaceae and Lamiaceae against foodborne
592
pathogens and spoilage bacteria. Ann Microbiol 2005; 55: 139–143.
593
[54] Saharkhiz MJ, Motamedi M, Zomorodian K, Pakshir K, Miri R, Hemyari K. Chemical
594
Composition, Antifungal and Antibiofilm Activities of the Essential Oil of Mentha piperita L.
595
ISRN Pharmaceutics 2012; doi:10.5402/2012/718645.
596
[55] Shunying Z, Yang Y, Huaidong Y. Chemical composition and antimicrobial activity of
597
the essential oils of Chrysanthemum indicum. J Ethnopharmacol 2005; 96: 151-8.
598
[56] Lambert RJW, Skandamis PN, Coote P, Nychas GJE, A study of the minimum
599
inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J
600
Appl Microbiol 2001; 91: 453-462.
601
[57] Lopez P, Sanchez C, Batle R, Nerin C. Solid and vaporphase antimicrobial activities of
602
six essential oils: susceptibility of selected food borne bacterial and fungal strains. J Agric
603
Food Chem 2005; 53 (17): 6939–6946.
604
[58] Angioni A, Barra A, Cereti E, Barile D, Coisson JD, Arlorio M, Dessi S, Coroneo V,
605
Cabras P. Chemical composition, plant genetic differences, antimicrobial and antifungal
606
activity investigation of the essential oil of Rosmarinus officinalis L. J Agric Food Chem
607
2004; 52 (11): 3530–3535.
608
[59] Celiktas OY, Kocabas EEH, Bedir E, Sukan FV, Ozek T, Baser KHC. Antimicrobial
609
activities of methanol extracts and essential oils of Rosmarinus officinalis, depending on
610
location and seasonal variations. Food Chem 2007; 100: 553–559.
AC C
EP
TE D
M AN U
SC
RI PT
587
28
ACCEPTED MANUSCRIPT [60] Gachkar L, Yadegari D, Rezaei MB, Taghizadeh M, Astaneh SA, Rasooli I. Chemical
612
and biological characteristics of Cuminum cyminum and Rosmarinus officinalis essential oils.
613
Food Chem 2007; 102: 898–904.
614
[61] Kalamba D, Kunicka A. Antibacterial and antifungal properties of essential oils. Curr
615
Med Chem 2003; 10: 813–829.
616
[62] Gill AO, Delaquis P, Russo P, Holley RA. Evaluation of antilisterial action of cilantro oil
617
on vacuum packed ham. Int J Food Microbiol 2002; 73: 83–92.
618
[63] Melchior MB, Vaarkamp H, Fink-Gremmels J. Biofilms: a role in recurrent mastitis
619
infections? Vet J 2006; 171: 398-407.
620
[64] Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of
621
persistent infections. Science 1999; 284: 1318–1322.
622
[65] Vialette M, Pinon A, Chasseignaux E, Lange M. Growth kinetics comparison of clinical
623
and sea food Listeria monocytogenes isolates in acid and osmotic environment. Int J Food
624
Microbiol 2003; 83: 12–131.
625
[66] Aiello AE, Cimiotti J, Della-Latta P, Larson EL. A comparison of the bacteria found on
626
the hands of ‘homemakers’ and neonatal intensive care unit nurses. J Hosp Infect 2003; 54:
627
310–315.
628
[67] Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. Lancet
629
2002; 359: 1135–1144.
630
[68] Elhariry H, Gherbawy Y, El-Deeb B, Altalhi A. Molecular identification and biofilm-
631
forming ability of culturable aquatic bacteria in microbial biofilms formed in drinking water
632
distribution networks. Geomicrobiol J 2012; 29: 561–569.
633
[69] Bavington C, Page C. Stopping bacterial adhesion: a novel approach to treating
634
infections. Respiration 2005; 72: 335–344.
AC C
EP
TE D
M AN U
SC
RI PT
611
29
ACCEPTED MANUSCRIPT
Table 1 : Chemical composition of Satureja montana L., Thymus vulgaris L. and Rosmarinus officinalis L. essential oils. Compounda
Retention index (RIb)
Percentage
RI PT
Peak number
S. montana L.
EP
SC
̶ 1.14 0.73 0.31 ̶ ̶ 0.15 0.86 ̶ 1.3 ̶ 0. 22 ̶ 1.76 13.03 0.73 ̶ 0.42 13.54 0.87 ̶ ̶ 1.81 ̶ ̶ ̶ ̶ 1.14 ̶ 0.5 ̶ 0.13 ̶
M AN U
921 927 934 949 954 974 978 981 987 992 1005 1006 1011 1018 1027 1030 1033 1033 1060 1070 1088 1089 1101 1107 1143 1148 1161 1170 1177 1181 1189 1194 1198
TE D
Tricyclene α-thujene α-pinene Camphene Verbenene Sabinene β-Pinene 1-Octen-3-ol 3-Octanone β-myrcene β-terpinene α-phellandrene δ-3-Carene α-terpinene p-cymene Limonene 1,8-cineole Eucalyptol γ-terpinene trans-sabinene hydrate α-Terpinolene Terpinolene Linalool 2,3-Dimethyl-2,3 Dihydropyridine Pinocarveol Camphor Isoborneol Borneol Isopinocamphone Terpinen-4-ol Cuminol α-terpineol Endo-isocamphonone
AC C
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
T. vulgaris L. ̶ 1.69 0.85 0.60 ̶ 0.09 0.24 0.39 ̶ 1.7 ̶ 0.27 0.11 2.02 18.08 0.85 0.34 ̶ 13.12 0.43 ̶ 0.23 2.44 ̶ ̶ ̶ ̶ 1.35 ̶ 0.96 ̶ 0.14 ̶
R. officinalis L. 0.15 0.07 19.49 8.65 0.11 ̶ 3.34 0.12 0.26 2.28 0.09 ̶ 0.39 ̶ 3.79 3.41 24.10 ̶ 0.07 ̶ 0.19 ̶ 1.08 0.15 0.26 19.87 0.30 2.91 0.11 0.42 0.18 1.86 0.15
32
ACCEPTED MANUSCRIPT
a
̶ 0.19 ̶ 0.89 ̶ 53.35 ̶ 0.19 0.15 2.23 ̶ ̶ ̶ 0.3 0.25 0.48 0.15 0.43 ̶ ̶
̶ ̶ 0.10 ̶ 0.33 41.33 5.24 ̶ ̶ ̶ ̶ 5.05 ̶ 0.15 0.14 0.45 0.25 ̶ ̶ 0.40 ̶ 0.30
0.21 0.80 ̶ 0.10 1.57 ̶ ̶ ̶ 0.17 ̶ ̶ 1.27 0.36 0.31 ̶ ̶ ̶ ̶ ̶ 0.70 0.09 ̶
99.85
99.64
99.38
33.2 59.11 5.72 0.58 1.24
39.85 50.88 5.9 0.7 0.96
42.03 52.04 1.94 0.79 2.37
̶
SC
RI PT
̶
TE D
M AN U
1200 1213 1236 1255 1289 1299 1308 1309 1351 1374 1390 1427 1446 1461 1473 1521 1521 1529 1588 1594 1621 1651
EP
Total identified Grouped components (%) Monoterpene hydrocarbons Oxygenated monoterpenes Sesquiterpene hydrocarbons Oxygenated sesquiterpenes Others
α-terpinene Verbenone Thymol methyl ether Linalyl acetate Bornyl acetate Thymol p-Cymene-3-ol Carvacrol α-Terpinyl acetate Carvacrol acetate β-Bourbonene β-caryophyllene Aromadendrene α-Humulene Lavandulyl acetate α-amorphene γ-cadinene δ-cadinene Spathulenol Caryophyllene oxide Humulene epoxide T-Cadinol
AC C
34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55
, Compounds are listed in order of their elution from the HP-5MS column. , Retention index calculated against C8–C26 n-alkanes mixture on HP-5MS column.
b
33
ACCEPTED MANUSCRIPT
Table 2 : Antibacterial activity of three essential oils against foodborne pathogen Salmonella spp. strains S. montana a
MIC
MBC
MIC
MBC
0.78 0.78
0.78 0.78
1.56 1.56
3.12 1.56
25 25
50 50
0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.39
0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.78 0.39 0.39 0.39 0.78
3.12 1.56 1.56 3.12 1.56 1.56 1.56 1.56 1.56 1.56 1.56 1.56
12.5 12.5 12.5 25 25 12.5 12.5 12.5 12.5 12.5 12.5 25
25 25 50 50 50 25 50 25 25 25 25 50
1.56 1.56 1.56 1.56 1.56 1.56 0.78 1.56 0.78 1.56 1.56 0.78
AC C
EP
Salmonella spp. strains Samples (date) S. spp (S1: 6554) Merguez (07-05-2012) S. spp (S2: 6877) Sandwich (16-05-2012) S. spp (S3: 6907) Salad (06-06-2012) S. spp (S4: 7215) Tajine (23-07-2012) S. spp (S5: 7466) Cheese (29-08-2012) S. spp (S6: 7643) Cheese (14-09-2012) S. spp (S7: 7945) Merguez (21-09-2012) S. spp (S8: 9487) Dinde (21-06-2013) S. spp (S9: 9340) Cooked meat (16-07-2013) S. spp (S10: 9681) Dinde (12-08-2013) S. spp (S11: 9812) Sandwich (28-08-2013) S. spp (S12: 9983) Merguez (30-09-2013) a , Minimum inhibitory concentration. b , Minimum bactericidal concentration.
R. officinalis
MBC
M AN U
ATCC 1408 LT2 DT104
b
TE D
Bacterial strains Salmonella typhimurium Salmonella typhimurium
MIC
RI PT
Antimicrobial susceptibility T. vulgaris
Origin
SC
Strains
34
ACCEPTED MANUSCRIPT
Table 3 : Antibiofilm effect of three essential oils against Salmonella spp. strains Strains
Inhibition of biofilm development (%) b
BIC50 (mg/ml)
RI PT
a
S. montana 1.15 0.85 4.5 0.68 0.75 0.6 3.125 3.00 5.375 6.00 6.45 6.25 5.50 5.50
BIC90 (mg/ml) T. vulgaris 2.78 3.50 7.25 6.60 6.00 5.51 3.12 6.11 6.21 5.51 4.62 6.89 7.51 7.00
R. officinalis 29.35 30.06 55.01 72.20 30.62 49.45 57.42 31.25 35.14 52.51 82.51 48.78 87.54 60.00
AC C
EP
TE D
M AN U
SC
S. montana T. vulgaris R. officinalis 2.31 0.106 S. typhimurium ATCC 1408 0.113 3.10 0.113 S. typhimurium LT2 DT104 0.22 3.51 0.725 S. spp (6554) 0.325 3.31 0.475 S. spp (6877) 0.195 0.462 2.94 S. spp (6907) 0.13 6.00 0.387 S. spp (7215) 0.24 3.44 S. spp (7466) 0.225 0.344 3.75 0.212 S. spp (7643) 0.121 2.06 0.205 S. spp (7945) 0.31 2.44 S. spp (9487) 0.565 0.197 6.25 0.112 S. spp (9340) 0.458 0.307 4.74 S. spp (9681) 0.499 6.75 S. spp (9812) 0.45 0.437 S. spp (9983) 0.21 0.19 5.37 a , minimum biofilm inhibition concentration of EOs that showed 50% inhibition on the biofilm formation. b , minimum biofilm inhibition concentration of EOs that showed 90% inhibition on the biofilm formation.
35
ACCEPTED MANUSCRIPT
Figure captions
RI PT
Figure 1 : Microscopic visualization of the effect of three essential oils on biofilm formation of Salmonella typhimurium ATCC 1408 cultured on glass slides covers. NC, Negative control ; PC, positive control (non treated slides). For Satureja montana L. EO S1, cells supplemented with EO MIC/2 ; S2, cells supplemented with EO MIC ; S3, cells supplemented with EO 2 × MIC. For Thymus vulgaris L. EO T1, cells supplemented with EO MIC/2 ; T2, cells supplemented with EO MIC ; T3, cells
SC
supplemented with EO 2 × MIC. For Rosmarinus officinalis L. EO R1, cells supplemented with EO MIC/2 ; R2,
M AN U
cells supplemented with EO MIC ; R3, cells supplemented with EO 2 × MIC.
Figure 2 : Microscopic visualization of the effect of three essential oils on biofilm formation of food isolated Salmonella spp. strain (S1) cultured on glass slides covers. NC, Negative control ; PC, positive control (non treated slides). For Satureja montana L. EO S1’, cells supplemented with EO MIC/2 ; S2’, cells supplemented with EO MIC ; S3’, cells supplemented with EO 2 × MIC. For Thymus vulgaris L. EO T1’, cells supplemented with EO MIC/2 ; T2’, cells supplemented with EO MIC ; T3’, cells
TE D
supplemented with EO 2 × MIC. For Rosmarinus officinalis L. EO R1’, cells supplemented with EO MIC/2 ; R2’, cells supplemented with EO MIC ; R3’, cells supplemented with EO 2 × MIC.
EP
Figure 3: Microscopic visualization of the effect of three essential oils on adhesion ability of Salmonella typhimurium ATCC 1408 to A549 cells. NC, negative control (A549 cells); PC, positives control (bacteria + A549 cells); For Satureja montana L. EO S1, cells supplemented with DL50 EO;
AC C
S2, cells supplemented with DL50×4 EO; For Thymus vulgaris L. EO T1, cells supplemented with DL50 EO; T2, cells supplemented with DL50×4 EO; For Rosmarinus officinalis L. EO R1, cells supplemented with DL50 EO; R2, cells supplemented with DL50×4 EO.
Figure 4: Microscopic visualization of the effect of three essential oils on adhesion ability of food isolated Salmonella spp. strain (S1) to A549 cells. NC, negative control (A549 cells); PC, positives control (S1 + A549 cells); For Satureja montana L. EO S1’, cells supplemented with DL50 EO; S2’, cells supplemented with DL50×4 EO; For Thymus vulgaris L. EO T1’, cells supplemented with DL50 EO; T2’, cells supplemented with DL50×4 EO; For Rosmarinus officinalis L. EO R1’, cells supplemented with DL50 EO; R2’, cells supplemented with DL50×4 EO; R3’, cells supplemented with DL50×8 EO.
36
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
Figure 1
37
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
Figure 2
38
AC C
EP
TE D
M AN U
Figure 3
SC
RI PT
ACCEPTED MANUSCRIPT
39
AC C
EP
TE D
M AN U
Figure 4
SC
RI PT
ACCEPTED MANUSCRIPT
40
ACCEPTED MANUSCRIPT
Highlights
1- Chemical composition of three medeterranien essential oils (EOs)
RI PT
2- EOs rich in phenolic compounds (carvacrol and thymol) had excellent anti-bacterial activities.
SC
3- Inhibition of biofilm formation to biotic and abiotic surfaces of different EOs
M AN U
4- The food isolated Salmonella spp. strains was more resistant that the reference strain to EOs activity
5- EOs had the potential to be used as food preservatives and may provide natural protection
AC C
EP
TE D
from the infection by some pathogenic bacteria
3